Cell and gene therapy: sustaining growth and maximizing opportunities

Cell and gene therapies are transforming the way diseases are treated. As research progresses it is hoped that cell and gene therapies will offer innovation for the future.

In this webinar, you will hear from CBO/CDO of Adthera Bio, Stuart Curbishley, Chief Executive Officer of Cell & Gene Therapy Catapult, Matthew Durdy, Scientific Solutions Consultant of Benchling, Brian Fan, and Founder and CEO of Dark Horse Consulting, Anthony Davies.

The event will cover aspects affecting growth of the CGT market, including how manufacturing technologies are enabling drug development, what these therapies mean for the healthcare market, and the opportunities for developers.

In this webinar, you will learn:
  • The opportunities cell and gene therapies offer drug discovery and development

  • How to sustain and maximize market growth

  • The challenges facing cell and gene therapies

  • Where are the opportunities for innovation? (autologous therapies/solid tumors/ indications outside of oncology?)

Watch now

Hosted by

Stuart Curbishley
CBO/CDO at Adthera Bio
Anthony Davies
Founder and CEO at Dark Horse Consulting
Brian Fan
Scientific Solutions Consultant at Benchling
Matthew Durdy
CEO at Cell and Gene Therapy Catapult

See Benchling in action

Helix Image